Drawing for AXISONE

USPTO serial 99386814

AXISONE

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MANRESA, MONICA L
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with AXISONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ERIC L ADLER

ERIC L ADLER PIRKEY BARBER PLLC1801 East 6th Street, Suite 300Austin, TX 78702United States

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services featuring software for life sciences experiment protocol design; Software as a service (SAAS) services featuring software for coordinating biospecimen access; Software as a service (SAAS) services featuring software for life sciences lab matching; Software as a service (SAAS) services featuring software for research and development in the field of life sciences, biology, biotechnology and pharmaceuticals; Software as a service (SAAS) services featuring software for coordinating laboratory research services; Software as a service (SAAS) services featuring software for scanning online academic and scientific databases to analyze and recommend effective research methods; Software as a service (SAAS) services featuring software for identifying laboratories that meet appropriate cost and capability requirements; Software as a service (SAAS) services featuring software for coordinating laboratory research in the fields of molecular biology services, genomics and bioinformatics, proteomics and metabolomics, cell biology and immunology, analytical chemistry and assay development, toxicology services, histopathology services (including virtual staining), biomarker discovery and validation, ai-powered image analysis, companion diagnostic and IVD development; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for life sciences experiment protocol design; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for coordinating biospecimen access; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for life sciences lab matching; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for research and development in the field of life sciences, biology, biotechnology and pharmaceuticals; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for coordinating laboratory research services; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for scanning online academic and scientific databases to analyze and recommend effective research methods; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for identifying laboratories that meet appropriate cost and capability requirements; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for coordinating laboratory research in the fields of molecular biology services, genomics and bioinformatics, proteomics and metabolomics, cell biology and immunology, analytical chemistry and assay development, toxicology services, histopathology services (including virtual staining), biomarker discovery and validation, ai-powered image analysis, companion diagnostic and IVD development; Software as a service (SAAS) services featuring software for connecting scientists to contract research organizationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Jun 9, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 14, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 14, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 8, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 18, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 11, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 3, 2026DOCKASSIGNED TO EXAMINER—
Feb 2, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 11, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 11, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance